Paper Titles

Innovative Synergistic Valorization of Lignite Fly Ash and Steel Industry Scrap-Soil as Secondary Resources for Compacted Ceramics
p.268

Layered Double Hydroxides (LDHs) Type Materials Used in Water Treatment
p.273

Removal of Iron and Total Chromium Contaminations in Landfill Leachate by Using Electrocoagulation Process
p.279

Synthesis of Alum from Discarded Aluminium Beverage Cans
p.284

The Biomaterial Relevance of Oxytocin in Some Zebrafish Studies
p.289

Characteristics Evolution of Transylvanian Sand after Biogrout Treatment
p.294

Review of Soil Stabilization Techniques: Geopolymerization Method one of the New Technique
p.298

Respiratory Parameters-Based Approach to Assessing Dust Loading
p.305

Determination Performance of Thermoacoustic Heat Engine Simulation by Delta EC Software
p.311

HomeKey Engineering MaterialsKey Engineering Materials Vol. 660The Biomaterial Relevance of Oxytocin in Some...

The Biomaterial Relevance of Oxytocin in Some Zebrafish Studies

Article Preview

Abstract:

Oxytocin is a nonapeptide hormone that is involved, besides its classical functions, in linking social signals with cognition, behaviors and reward. Also, it seems to have a critical role in the regulation of brain-mediated processes that are strongly relevant to many neuropsychiatric disorders. In this way, in the present paper we will try to describe the most important and modern aspects regarding the relevance of oxytocin administration in various animal models of neuropsychiatric disorders, as well as in human patients. Also, the relevance of zebrafish studies in this context will be extensively discussed.

You might also be interested in these eBooks

Innovative Materials and Engineering Research

Info:

Periodical:

Key Engineering Materials (Volume 660)

Pages:

289-293

DOI:

https://doi.org/10.4028/www.scientific.net/KEM.660.289

Citation:

Cite this paper

Online since:

August 2015

Authors:

Gabriel Plavan, Ciobica Alin, Mircea Nicoara, Daniel Timofte

Keywords:

Animal Models, Neuropsychiatric Disorders, Oxytocin, Zebrafish

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

© 2015 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] D. Cochran, M. Hill, J. Frazier, The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings, Harv. Rev. Psychiatry. 21 (2013) 219-47.

DOI: 10.1097/hrp.0b013e3182a75b7d

[2] K. Macdonald, T. Macdonald, The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans, Harv. Rev. Psychiatry. 18 (2010) 1–21.

DOI: 10.3109/10673220903523615

[3] D. Marazziti, M. Catena Dell'osso, The role of oxytocin in neuropsychiatric disorders, Curr Med Chem. 15 (2008) 698-704.

[4] D. Feifel, Oxytocin as a potential therapeutic target for schizophrenia and other neuropsychiatric conditions, Neuropsychopharmacology. 37 (2012) 304-5.

DOI: 10.1038/npp.2011.184

[5] R. Levin, S. Edelman, I. Shalev, P. Ebstein, U. Levy, Brain Protection in Schizophrenia, Mood and Cognitive Disorders - The Role of Oxytocin in Neuropsychiatric Disorders, Concepts and Mechanisms. 1 (2010) 611-635.

DOI: 10.1007/978-90-481-8553-5_20

[6] S. Jesso, D. Morlog, S. Ross, M. Pell, A. Kertesz, E. Finger, The effects of oxytocin on social cognition and behaviour in frontotemporal dementia, Brain. 134 (2011) 2493-501.

DOI: 10.1093/brain/awr171

[7] L. Hanson, J. Fine, A. Svitak, K. Faltesek, Intranasal administration of CNS therapeutics to awake mice, J. Vis. Exp. 1 (2013) 74.

DOI: 10.3791/4440

[8] M. Uchida, T. Katoh, M. Mori, T. Maeno, Y. Morimoto, H. Natsume, Intranasal administration of milnacipran in rats: evaluation of the transport of drugs to the systemic circulation and central nervous system. Biol. Pharm. Bull. 34 (2011) 740-7.

DOI: 10.1248/bpb.34.740

[9] T. Schneider, R. Przewłocki, Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology. 30 (2005) 80-9.

DOI: 10.1038/sj.npp.1300518

[10] R. Kumar, J. Seema, Sodium Orthovanadate Treatment Reverses Methionine Administration Induced Schizophrenia Like Behavior in Rats, Iran Pharm Ther. 6 (2007) 67-70.

[11] A. Becker, G. Grecksch, Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity, Prog. Neuro. Biol. Psy. 28 (2004) 1267-77.

DOI: 10.1016/j.pnpbp.2004.06.019

[12] R. Zhang, J. He, S. Zhu, H. Zhang, Q. Tan, X. Li, Myelination deficit in a phencyclidine-induced neurodevelopmental model of schizophrenia. Brain Res. 21 (2012) 136-43.

DOI: 10.1016/j.brainres.2012.06.003

[13] R. Lefter, D. Cojocaru, A. Ciobica, M. Paulet, I. Serban, E. Anton, Aspects of animal models for the major neuropsychiatric disorders, Arch. of Bio. Sci. 66 (2014) 105-1115.

DOI: 10.2298/abs1403105l

[14] C. Modahl C, Green L, Fein D. Plasma oxytocin levels in autistic children. Biol. Psychiatry. 43 (1998) 270–277.

DOI: 10.1016/s0006-3223(97)00439-3

[15] E. Hollander, S. Novotny, M. Hanratty, Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders, Neuropsychopharmacology. 28 (2003) 193–198.

DOI: 10.1038/sj.npp.1300021

[16] C. Epperson, C. McDougle, L. Price. Intranasal oxytocin in obsessive-compulsive disorder, Biol. Psychiatry. 40 (1996) 547–549.

DOI: 10.1016/0006-3223(96)00120-5

[17] A. Guastella, A. Howard, M. Dadds, P. Mitchell , D. Carson, A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder, Psychoneuroendocrinology. 34 (2009) 917–923.

DOI: 10.1016/j.psyneuen.2009.01.005

[18] G. Scantamburlo, M. Hansenne, S. Fuchs S, Plasma oxytocin levels and anxiety in patients with major depression, Psychoneuroendocrinology. 32 (2007) 407–410.

DOI: 10.1016/j.psyneuen.2007.01.009

[19] A. Frasch, T. Zetzsche, A Steiger, G. Jirikowski, Reduction of plasma oxytocin levels in patients suffering from major depression, Adv. Exp. Med. Biol. 395 (1995) 257–258.

[20] L. van Londen, J. Goekoop, G. van Kempen, Plasma levels of arginine vasopressin elevated in patients with major depression, Neuropsychopharmacology. 17 (1997) 284–292.

DOI: 10.1016/s0893-133x(97)00054-7

[21] U. Anderberg, K. Uvnas-Moberg, Plasma oxytocin levels in female fibromyalgia syndrome patients. Zeitschrift fur Rheumatologie. 59 (2000) 373–379.

DOI: 10.1007/s003930070045

[22] H. Beckmann, R. Lang, W. Gattaz, Vasopressin—oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls, Psychoneuroendocrinology. 10 (2005) 187–19.

DOI: 10.1016/0306-4530(85)90056-3

[23] D. Glovinsky, K. Kalogeras, D. Kirch, R. Suddath, R. Wyatt, Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication, Schizophr. Res. 11 (1994).

DOI: 10.1016/0920-9964(94)90021-3

[24] Z. Iqbal, Z. Rahman, F. Muhammad, S. Awais, S. Sadaf, Oxytocin induced oxidative stress in lactating Bubalis bubalis (Nili Ravi), BMC. Veterinary Research. 9 (2013) 169.

DOI: 10.1186/1746-6148-9-169

[25] T. Mostafa, L. Rashed, I. Osman, M. Marawan, Seminal plasma oxytocin and oxidative stress levels in infertile men with varicocele, Andrologia. 47 (2015) 209-13.

DOI: 10.1111/and.12248

[26] T. Manoj, M. Murugan, Influence of Demoxytocin on the Behavioural Actions of Melatonin, Journal of Experimental Sciences. 2 (2011) 7-9.

[27] S. Wu, M. Jia, Y. Ruan, Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biol. Psychiatry. 58 (2005) 74–7.

DOI: 10.1016/j.biopsych.2005.03.013

[28] E. Lerer, S. Levi, S. Salomon, A. Darvasi, B. Ebstein, Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition, Mol. Psychiatry. 13 (2008) 980–8.

DOI: 10.1038/sj.mp.4002087

[29] C. Yrigollen, S. Han, A. Kochetkova A, Genes controlling affiliative behavior as candidate genes for autism, Biol. Psychiatry. 63 (2008) 911–6.

DOI: 10.1016/j.biopsych.2007.11.015

[30] R. Souza, P. Ismail, H. Meltzer, J. Kennedy, Variants in the oxytocin gene and risk for schizophrenia, Schizophr. Res. 121 (2010) 279–80.

DOI: 10.1016/j.schres.2010.04.019

[31] B. Costa, S. Pini, P. Gabelloni P, Oxytocin receptor polymorphisms and adult attachment style in patients with depression, Psychoneuroendocrinology. 34 (2009) 1506–14.

DOI: 10.1016/j.psyneuen.2009.05.006

[32] G. Gimpl, F. Fahrenholz F, The oxytocin receptor system: structure, function, and regulation, Physiological Reviews. 81 (2001) 629–83.

DOI: 10.1152/physrev.2001.81.2.629

[33] H. Zingg, S. Laporte, The oxytocin receptor, Trends in Endocrinology and Metabolism. 14 (2003) 222–7.

DOI: 10.1016/s1043-2760(03)00080-8

[34] J. Silk, S. Alberts, J. Altmann, Social bonds of female baboons enhance infant survival. Science. 302 (2003) 1231–1234.

DOI: 10.1126/science.1088580

[35] Z. Hall, A. De Serrano, F. Rodd, V. Tropepe, Casting a wider fish net on animal models in neuropsychiatric research. Prog. Neuropsychopharmacol. Biol. Psychiatry. 55 (2014) 7-15.

DOI: 10.1016/j.pnpbp.2014.04.003